DPLO - Diplomat Pharmacy Q2 2019 Earnings Preview

August, 08 2019 05:30 PM Diplomat Pharmacy Inc.

Diplomat Pharmacy (NYSE:DPLO) is scheduled to announce Q2 earnings results on Friday, August 9th, before market open.
The consensus EPS Estimate is $0.07 (-58.8% Y/Y) and the consensus Revenue Estimate is $1.23B (-13.4% Y/Y).
Over the last 2 years, DPLO has beaten EPS estimates 63% of the time and has beaten revenue estimates 13% of the time.
Over the last 3 months, EPS estimates have seen 1 upward revision and 3 downward. Revenue estimates have seen 3 upward revisions and 5 downward.
More news on: Diplomat Pharmacy, Inc., Earnings news and commentary, , Healthcare stocks news,